uniQure N.V. Financial Ratios
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
uniQure N.V. ratio analysis
uniQure N.V. earned a net margin of -1236.0% in FY 2025, down from -883.4% a year earlier. Gross margin was 89.5% compared with a median of 94.6% over the prior 9 years. Return on equity reached -100.0%, meaning uniQure N.V. generated -1.00 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.25, and the current ratio was 10.43. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
uniQure N.V. financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | — | 2.95 | — | — | — | — | — |
| Price / sales | 83.55 | 32.18 | 20.37 | 9.95 | 1.82 | 42.83 | 392.14 | 88.88 | 40.33 | 5.59 |
| Price / book | 6.76 | — | 1.55 | 2.23 | 1.60 | 6.59 | 8.84 | 5.58 | 5.92 | 2.20 |
| Gross margin | 89.5% | 95.3% | 99.6% | 98.8% | 95.2% | 92.3% | 77.3% | 89.3% | 93.8% | 94.6% |
| Operating margin | -1,151.4% | -679.6% | -1,785.5% | -134.4% | 59.3% | -334.3% | -1,663.8% | -781.9% | -544.3% | -286.7% |
| Net margin | -1,236.0% | -883.4% | -1,947.1% | -119.1% | 62.9% | -333.3% | -1,705.8% | -738.2% | -604.7% | -292.3% |
| Free cash flow margin | -1,108.2% | -686.2% | -966.3% | -152.8% | 51.6% | -378.8% | -1,433.0% | -695.0% | -524.4% | -348.5% |
| Return on equity (ROE) | -100.0% | — | -148.5% | -26.6% | 55.3% | -51.3% | -38.4% | -46.4% | -88.7% | -115.3% |
| Return on assets (ROA) | -24.1% | -43.0% | -37.1% | -18.0% | 40.7% | -36.7% | -27.7% | -30.4% | -37.8% | -38.6% |
| Debt / equity | 0.25 | — | 0.49 | 0.22 | 0.17 | 0.15 | 0.11 | 0.20 | 0.23 | 0.32 |
| Current ratio | 10.43 | 9.74 | 8.85 | 6.28 | 17.09 | 9.47 | 12.15 | 11.85 | 8.47 | 6.34 |
| Revenue growth | -40.6% | 71.2% | -85.1% | -79.7% | 1,296.8% | 415.2% | -35.5% | -13.9% | -47.8% | 137.3% |
| EPS growth | — | — | — | -138.5% | — | — | — | — | — | — |